▮ DFV TERMINAL
--:--:-- UTC SIGN IN
F1 Terminal / CCEL

CCEL — CRYO CELL INTERNATIONAL INC

—
NYSE · Health Care · Health Care Providers & Services · CIK 862692 ·
Last close
$3.42
Market Cap
$27.55M
52W High
$4.10
52W Low
$2.90
ADV30
8,811
Next earnings
—
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Feb 2026 7,683,117 6,026,629 765,134 47,108 60,884,986 249,672 79,285,258
Nov 2025 7,843,166 6,109,064 392,047 -3,817,433 61,728,514 319,031 80,334,443
May 2025 7,928,843 6,072,304 1,492,634 355,785 64,437,909 137,491 79,997,714
Feb 2025 7,968,880 5,984,292 1,056,011 282,855 64,381,067 223,122 79,037,376

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$3,593,717
Investing CF
$-2,060,829
Financing CF
$-1,971,892
CapEx
$-258,752
Dividends Paid
$-3,231,227
Buybacks
$-88,619
EPS Diluted TTM
$0.21
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-38,391,130
Inventory
$356,991
Receivables
$6,815,692
ST Investments
$2,650,386
EBIT TTM
$-1,462,094
Pretax Income TTM
$-3,452,840
Interest Exp TTM
$1,990,746
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$31,280,558
EBITDA
$1,172,961
Free Cash Flow
$159,919
Enterprise Value
$36,320,940
Total Cash
$2,900,058
Total Debt
$10,713,821
Shares Out
8,055,150
Trailing EPS
$-0.32
Book Value
$-2.28
ROE
—
ROA
0.2%
Div Yield
17.19%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Nov 2025 31,566,321 4,841,228 -2,429,385 61,728,514 80,334,443 — 5,478,606
Nov 2024 31,986,106 3,788,284 402,095 64,677,633 77,893,650 — 6,010,910
Nov 2023 31,343,695 3,490,187 -9,521,669 61,220,770 72,252,002 — 8,919,754
Nov 2022 30,336,749 4,459,800 2,771,408 64,888,054 66,412,356 — 8,572,647

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.02

Peers — same industry

TickerNameMarket CapLastDaily %
EHSI Elite Health Systems Inc. $28.52M $1.00 —
MDXH MDxHealth SA $24.45M $0.48 —
PIII P3 Health Partners Inc. $32.59M $9.80 —
CDIX Cardiff Lexington Corp $22.92M $1.50 —
EUDA EUDA Health Holdings Ltd $33.72M $11.26 —

News headlines (Yahoo Finance, 1h cache)

[Latest] Global Umbilical Cord Blood Banking Market Size/Share Worth USD 51.67 Billion by 2034 at a 11.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentati
2025-08-26 08:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.
SEC EDGAR filings → · StockAnalysis.com → · OpenInsider →